Nautilus Biotechnology (NAUT) Other financing activities (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Other financing activities data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities rose 6038.89% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 285.52% YoY), and the FY2025 full-year result was $58000.0, down 88.93% from the prior year.
• Other financing activities rose to $1.1 million in Q1 2026, from -$29000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.1 million in Q1 2026 to a low of -$29000.0 in Q4 2025.
• A 5-year average of $132562.5 and a median of $43000.0 in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities soared 24400.0% in 2024 and slumped 112.34% in 2025, its largest moves.
• Tracing NAUT's Other financing activities over 5 years: stood at $56000.0 in 2022, then sank by 78.57% to $12000.0 in 2023, then surged by 1858.33% to $235000.0 in 2024, then tumbled by 112.34% to -$29000.0 in 2025, then surged by 3910.34% to $1.1 million in 2026.
• Business Quant data shows NAUT's Other financing activities at $1.1 million in Q1 2026, -$29000.0 in Q4 2025, and $69000.0 in Q2 2025.